-
The Ministry of Emergency Management approves the industry standard "Guidelines for Safety Management of Chemical Processes
Time of Update: 2022-12-30
The "Guidelines for Chemical Process Safety Management" (AQ/T 3034-2022) aims to comprehensively identify risks and control risks, and each element is a high-level summary and induction of the causes of various accidents, which is of great significance for better guidance and promotion of chemical enterprises to accelerate the management level of process safety management elements, improve the ability to prevent and resolve major safety risks, and promote the continuous and stable improvement of the national chemical safety production situation.
-
Notice of Dazhou Market Supervision Administration on Food Safety Supervision and Sampling in 2022 (No. 18 of 2022
Time of Update: 2022-10-19
In accordance with the requirements of the Notice of Dazhou Market Supervision Administration on Issuing the Food Safety Sampling and Monitoring Plan of the City-wide Market Supervision System and th
-
Notice on Public Solicitation of "Guiding Principles for Evaluation of Immune-Related Adverse Events in Anti-tumor Therapy (Draft for Comment
Time of Update: 2021-12-05
pdf 2 "Technical Guidelines for Evaluation of Immune-related Adverse Events in Anti-tumor Therapy (Draft for Comment)" feedback form.
docx2 "Technical Guidelines for Evaluation of Immune-related Adverse Events in Anti-tumor Therapy (Draft for Comment)" feedback form.
-
FDA approves new treatment for HER2-positive breast cancer patients
Time of Update: 2021-02-24
Today, the U.S. Food and Drug Administration (FDA) has accelerated approval of Enhertu (fam-trastuzumab deruxtecan-nxki) for treatment of adult HER2-positive breast cancer patients who cannot be removed (cannot be surgically removed) or metastasis have received two or more anti-HER2-based treatments in a metastasis environment.
-
Haste makes waste? The FDA's Vaccine Advisory Committee explores the pros and cons of granting the new crown vaccine EUA
Time of Update: 2020-10-29
in the FDA's recently released guidelines for the authorization of emergency use of COVID-19 vaccines, it is clear that it is hoped that vaccine development companies will continue to collect efficacy and safety data in blind conditions after obtaining EUA approval.
-
Hundreds of competitions - what Chinese pharmaceutical companies do by whose WHO PQ certification
Time of Update: 2020-06-01
There is no doubt that China's pharmaceutical industry, as a pivotal part of the world pharmaceutical industry, has been deeply involved in all aspects of the world pharmaceutical industry cooperation
-
European Medicines Agency: Advanced Therapeutic Classification granted to MB-107 slow virus gene therapy for the treatment of X chain of severe comprehensive immunodeficiency disease
Time of Update: 2020-05-29
Mustang is a clinical biopharmaceutical company dedicated to the treatment of hematologic tumors, solid tumors and rare genetic diseases using cell and gene therapy Recently, the European Medicines
-
Zhongsheng Pharmaceutical Co develops a new drug zsym006 for the treatment of liver cancer
Time of Update: 2016-02-22
Announcement of Guangdong Zhongsheng Pharmaceutical Co., Ltd on the signing of Technology Development (cooperation) contract between the company and Shanghai yaomingkant new drug development Co., Ltd
-
PDUFA added the composite pharmacy charging version
Time of Update: 2014-04-04
Source: China Council for the promotion of drugs 2014-04-04 FDA intends to let compound pharmacy provide funds for inspection Regulatory focus (RF) reports that the FDA has released draft guidelines t
